Table 3.
Correlation between fibrinogen levels and mortality
| Predictors | OR (95% CI) | P valuea |
|---|---|---|
| 3-month mortality for patients with fibrinogen level < 2.0 g/L | ||
| Age | 1.035 (1.019–1.051) | < .001 |
| GCS | 0.811 (0.739–0.891) | < .001 |
| Pupillary reactions | 2.240 (1.467–3.421) | < .001 |
| EDH | 0.280 (0.149–0.526) | < .001 |
| INR | 4.316 (1.556–11.975) | .005 |
| FIB | 0.522 (0.273–0.995) | .048 |
| 3-month mortality for patients with fibrinogen level < 2.0 g/L vs. ≥ 2.0 g/L groups | ||
| AGE | 1.035 (1.024–1.047) | < .001 |
| GCS | 0.760 (0.716–0.807) | < .001 |
| Pupillary reactions | 1.874 (1.404–2.500) | < .001 |
| EDH | 0.399 (0.253–0.630) | < .001 |
| PT | 1.215 (1.125–1.312) | < .001 |
| FIBGb | 0.622 (0.439–0.882) | .008 |
GCS Glasgow Coma Scale, INR international normalized ratio, PT prothrombin, FIB fibrinogen, EDH epidural hematoma, SDH subdural hematoma
aP values adjusted for multiple comparisons. Statistical significance determined by multiple logistic regression analysis
bFIBG means patients with fibrinogen level < 2.0 g/L or ≥ 2.0 g/L groups